Search results
Transcenta’s Osemitamab succeeds in Phase IIa G/GEJ cancer triple combo trial
Clinical Trials Arena via Yahoo Finance· 39 minutes agoThe TranStar102 study (NCT04495296) investigated osemitamab in combination with Opdivo (nivolumab)...
TILT Biotherapeutics reports data from Phase I trial of ovarian cancer treatment
Clinical Trials Arena via Yahoo Finance· 47 minutes agoFinnish biotechnology company TILT Biotherapeutics has announced results from a Phase I clinical...
Pipeline Moves: Phase III AML trial fails to meet primary endpoint
Clinical Trials Arena via Yahoo Finance· 3 hours agoThis week on Pipeline Moves, we kick off by looking at a Phase III trial of GlycoMimetics’...
Innovent’s psoriasis treatment picankibart meets all endpoints in Phase III trial
Clinical Trials Arena via Yahoo Finance· 2 hours agoChinese biopharmaceutical company Innovent Biologics has reported that its Phase III CLEAR-1 study...
Insmed’s stock rockets toward a 2-decade high after positive drug-trial data
Market Watch· 28 minutes agoShares of Insmed Inc. skyrocketed Tuesday, after the biopharmaceutical company said it plans to file a New Drug Application for its treatment of non-cystic fibrosis bronchiectasis following ...
NS Pharma reports data from Phase III Duchenne treatment trial
Clinical Trials Arena via Yahoo Finance· 3 hours agoNS Pharma, a subsidiary of Japanese pharmaceutical company Nippon Shinyaku, has announced...
Here's how much young baby boomers have saved for retirement — how do you stack up in 2024?
Moneywise via AOL· 1 hour agoThe youngest among the baby boomer generation are set to retire over the next few years. But are...
AstraZeneca-Daiichi's Enhertu follow-up unable to prove overall survival benefit in phase 3
FierceBiotech· 28 minutes agoDaiichi Sankyo and antibody-drug conjugate (ADC) partner AstraZeneca have already filed their...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 26 minutes ago- New Positive Phase 2 Results in Metastatic Triple Negative Breast Cancer (mTNBC) Indicate That Use of Trilaciclib in Combination with a TROP2 ADC May Be Associated with ...
Oncology research booms: Global investigator sites double in just five years
BioPharma-Reporter· 33 minutes agoPhesi analyzed 11,755 phase 1, 2 and 3 oncology clinical trial sites open for recruitment since 2019...